Symposium 1
Antiresorptives: What We’ve Learned and What Lies Ahead
Day 2 (May 30, Fri) 11:10-12:25Room 1
-
Denosumab Beyond 10 Years: Balancing Long-Term Benefits and Risks
Michael R McClung
(Oregon Osteoporosis Center, USA)
-
Timing Matters in Denosumab: Planning Ahead to Prevent Rebound Fractures
Kyoung Min Kim
(Yonsei University, Korea)
-
Beyond Bone Health: Exploring the Mortality Impact of Antiresorptive Therapy
Kyoung Jin Kim
(Korea University, Korea)
Symposium 2
Advances in Bone Research: Signaling Pathways of Osteoblasts
Day 2 (May 30, Fri) 11:10-12:25Room 2
-
Mechanical Regulation of Angiogenesis-Osteogenesis Coupling during Bone Regeneration
Chao Liu
(Southern University of Science and Technology, China)
-
A Novel PTH(1-34) Signaling Pathway in Osteoblasts
Ji Hyun Park
(Jeonbuk National University, Korea)
-
Regulation of BMP2 Signaling for Bone Regeneration and Clinical Research
Eui Kyun Park
(Kyungpook National University, Korea)
Symposium 3. Keynote Symposium
AI in Action: Transforming Translational and Clinical Paradigms
Day 2 (May 30, Fri) 13:25-14:40Room 1
-
AI-Driven Drug Discovery in the Large Language Model Era
Jaewoo Kang
(Korea University, Korea)
-
Incorporating AI in Assessing Fracture Risk: Predicting the Unpredictable
Sung Hye Kong
(Seoul National University, Korea)
-
Developing AI-Driven Digital Biomarkers for Sarcopenia Detection
Jun-Il Yoo
(Inha University, Korea)
Symposium 4
Rare Bone Diseases: Unraveling Challenges and Advancing Solutions
Day 3 (May 31, Sat) 11:20-12:35Room 1
-
New Horizons in XLH Management: Burosumab and Beyond
Adalbert Raimann
(Medical University of Vienna, Austria)
-
Get Straight to the Source of Hypophosphatasia
Eric Rush
(Children's Mercy Kansas City, USA)
-
Rare Bone Disease in Korea: Current Challenges and Future Directions
Yumie Rhee
(Yonsei University, Korea)
Symposium 5
KSBMR-KCR Joint Symposium: Osteoimmunology
Day 3 (May 31, Sat) 11:20-12:35Room 2
-
Macrophages in the Regulation of Osteoimmune Homeostasis
Eun-Ju Chang
(University of Ulsan, Korea)
-
Peripheral Circadian Rhythm Disruption as a Potential Driver of Age-Related ECM Destruction in Osteoarthritis
Je-Hwang Ryu
(Chonnam National University, Korea)
-
Molecular and Cellular Basis of Joint Destruction in Rheumatoid Arthritis
Seungwoo Han
(Kyungpook National University, Korea)
Symposium 6
The Next Frontier in Bone Health: Exploring Anabolic Strategies Across Contexts
Day 3 (May 31, Sat) 15:00-16:15Room 1
-
Effects of Anabolics on Bone: Bridging the Gap between Clinical Trials and Real-World Practice
Ha Young Kim
(University of Ulsan, Korea)
-
Transforming Fracture Care: Paradigm Shifts with Anabolic Therapies
Jae Hyuk Yang
(Korea University, Korea)
-
Anabolics in Cancer Patients: To Use or Not to Use?
A Ram Hong
(Chonnam National University, Korea)
Symposium 7
Rewiring Muscle Biology: From Stem Cells to Therapeutic Innovations
Day 3 (May 31, Sat) 15:00-16:15Room 2
-
Circulating Pro-Aging Factors in Sarcopenia: Biomarker Potential and Therapeutic Perspective
Beom-Jun Kim
(University of Ulsan, Korea)
-
The Aging Body Plan
Miguel A. Esteban
(Chinese Academy of Sciences, China)
-
Thermogenesis in Muscle and Brown Fat
Xingxing Kong
(Fudan University, China)
Luncheon Symposium 1
Day 2 (May 30, Fri) 12:25-12:40Room 1
Luncheon Symposium 2
Day 2 (May 30, Fri) 12:25-12:40Room 2
-
TBD
TBD
(TBD)
Luncheon Symposium 3
Day 3 (May 31, Sat) 12:35-12:50Room 1
-
TBD
TBD
(TBD)
Luncheon Symposium 4
Day 3 (May 31, Sat) 12:35-12:50Room 2
-
TBD
TBD
(TBD)